JAK2 and breast carcinoma: Moreover, although not statistically significant, we found a pattern of poor survival in TCGA breast cancer patients expressing high PDGFRβ with low JAK2 levels compared to patients expressing low PDGFRβ with high JAK2 levels (HR:1.507, logrank: 0.00804) (Fig. 3k).